Home / News / OneVentures pumps up artificial heart group BiVACOR

OneVentures pumps up artificial heart group BiVACOR

Read the full article: The Australian Financial Review

30 March 2023

Posted in — News, The Australian Financial Review

Share
Share

You may also like

18 June 2023

Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch

News, Announcement

06 December 2022

Needle-free vaccine innovator banks $34m

News, The Australian Financial Review

10 November 2021

Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021

News

19 October 2021

Blade Therapeutics Initiates Additional Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis

Media Release

View All

Ventured. Gained.

Subscribe to our Newsletter.

Name
decor
decor decor decor
decor decor decor decor decor